MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
MNKD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

MannKind (MNKD) Ownership - Who owns MannKind?

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
1 Casper Street
Phone
+1 818 661-5000
Employees
592
Web
https://www.mannkindcorp.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.13B
P/E Ratio
143.00
Total Cash
133.86M
Projected Growth
N/A
Total Debt
330.96M
Revenue
360.78M
Risk (Beta)
1.12
Dividend Yield
N/A
Total Cash/Share
0.43
Total Debt/Equity
992.55
Revenue/Share
1.16 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
MNKD
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for MNKD
A.I. Advisor
published General Information

General Information

a developer of therapeutic products

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
1 Casper Street
Phone
+1 818 661-5000
Employees
592
Web
https://www.mannkindcorp.com